血清脂肪酶检测在病毒性肝炎中的临床意义  

Clinical significance of lipase detection in viral hepatitis patients

作　　者：尹有美[1] 窦宇明[1] 于立新[1] 沈桂堂[1] 王蔚[1] 张丽丽[1] 

机构地区：[1]江苏省泰州市人民医院感染科,225300

出　　处：《中华全科医师杂志》2012年第12期930-931,共2页Chinese Journal of General Practitioners

摘　　要：923例病毒性肝炎患者中，血清脂肪酶（LPS）升高54例（5．85％）。病毒性肝炎患者随着血清总胆红素水平升高，血清LPS水平逐渐增高，差异有统计学意义（P〈0．01）。54例LPS升高患者，死亡11例，其LPS持续异常率6／11，而生存组异常率为4．65％（2／43），差异有统计学意义（P〈0．01）。提示，病毒性肝炎可合并血清LPS升高，LPS升高反映肝炎病情加重，LPS持续升高与患者病情严重程度及预后有关。Lipase of 54/923 cases increased in viral hepatitis group with an abnormal rate of 5.85%. Lipase level of viral hepatitis patients gradually increased with the rising total bilirubin levels, and the difference was statistically significant （P 〈 0. 01 ）. Among 54 viral hepatitis cases with elevated lipase, 11 died. The sustained abnormal rate of lipase （6/11） of the death group was statistically significant vs. 4. 65% （2/43） of the survival group（P 〈0. 01 ）. Thus viral hepatitis could be concomitant with elevated lipase and elevated lipase might promote the progression of liver disease. The continuing rise of lipase is correlated with the severity and prognosis of the patients.

关 键 词：肝炎 病毒性 人 脂肪酶 

分 类 号：R446[医药卫生—诊断学] R51[医药卫生—临床医学]